Deprenyl and the Issue of Neuroprotection F. Vingerhoets, MD, Neurodegenerative Disorders Centre, University Hospital, UBC Site, Purdy Pavilion, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5 (Canada) The Parkinson Disease Study Group (PDSG) recently published its findings concerning antioxidant drug therapy for early Parkinson’s disease [1] (idiopathic parkinsonism (IP)) as follow-up to an earlier ...

drug clorgyline. Type B enzyme (or enzymes) deaminates only dopamine and is inhibited by deprenyl. The clinical papers include presentations and discussion by pioneers in the use of monoamine oxidase inhibitors in clinical states. Pare's observation that some bipolar depressions respond only to monoamine oxidase inhibitors is in accord with some clinical observations made at Yale by Himmelhoch ...